Clinical Trial Packaging and Labelling Market Forecast 2020-2030
Revenue Prospects by Type (Primary Packaging (Blisters, Bottles, Pouches, Tubes, Others), Secondary Packaging (Labelling for Parenteral and Injectable, Just in Time Labelling, Tyvek Blistering for Parenteral, Cartons, Others)), End Users (Drug Manufacturing Companies, Research Labs and CROs), Profiles of Leading Companies in Clinical Trial Packaging and Labelling PLUS Regional and Leading National Market Analysis
Clinical Trials Packaging and Labelling- our new study reveals trends, R&D progress, and predicted revenues Where is the Clinical Trial Packaging and Labelling market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 171 pages report provides 96 tables, 50 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Clinical Trial Packaging and Labelling Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.
Clinical Trial Packaging and Labelling Market by Type
Secondary Packaging • Labelling for Parenteral and Injectable • Just in Time Labelling • Tyvek Blistering for Parenteral • Cartons • Others
Clinical Trial Packaging and Labelling Market by End Users • CRO’s • Drug Manufacturing Companies • Research Labs
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
North America • U.S. • Canada • Latin America: • Brazil • Mexico • Rest of Latin America
Europe (EU) • Germany • France • UK • Italy • Spain • Rest of Europe
Asia-Pacific (APAC) • Japan • China • India • Australia • ASEAN • Rest of Asia-Pacific
Middle East and Africa (MEA) • GCC Countries • South Africa • Rest of MEA
Leading companies covered in this report include: • Fisher Clinical Services, Inc. • The Coghlan Group, Inc. • Mawdsley-Brooks & Co. Ltd • Piramal Enterprises Ltd • Sharp • Corden Pharma GmbH • Bilcare Limited • Westrock Company • Sentry Biopharma Services • Körber Medipak Systems AG • PCI Pharma Services • Nextpharma Technologies • CSM
The report also includes profiles and for some of the leading companies in the Clinical Trial Packaging and Labelling market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth Overall world revenue for Clinical Trial Packaging and Labelling Market will surpass $900 million in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Clinical Trial Packaging and Labelling Market report helps you In summary, our 181 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for 5 regional and 17 key national markets- See forecasts for the Clinical Trial Packaging and Labelling market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
• Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Clinical Trial Packaging and Labelling market Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Clinical Trial Packaging and Labelling market and leading companies. You will find data, trends and predictions.
Buy our report today Clinical Trial Packaging and Labelling Market Forecast 2020-2030: Revenue Prospects by Type (Primary Packaging (Blisters, Bottles, Pouches, Tubes, Others), Secondary Packaging (Labelling for Parenteral and Injectable, Just in Time Labelling, Tyvek Blistering for Parenteral, Cartons, Others)), End Users (Drug Manufacturing Companies, Research Labs and CROs), Profiles of Leading Companies and Regional and Leading National Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Global Clinical Trials Packaging and Labelling Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Clinical Trials Packaging and Labelling Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Introduction to Clinical Trials Packaging and Labelling
2.1 Types of Packages
2.1.1 Syringes
2.1.2 Bottles
2.1.3 Blisters
2.1.4 Cold Forming
2.1.5 Thermoforming
2.1.6 Tubes
2.1.7 Vials and Ampoules
2.1.8 Bags
2.1.9 Pouches
2.1.10 Sachets
2.1.11 Cups and Closures
2.1.12 Containers, Cartons, and Boxes
2.2 Types of Packaging Materials
2.2.1 Polyvinyl Chloride (PVC)
2.2.2 High Density Polyethylene (HDPE)
2.2.3 Low Density Polyethylene (LDPE)
2.2.4 Polypropylene (PP)
2.2.5 Glass
2.2.6 Metal
2.2.7 Paper
2.2.8 Corrugated Fibre
3 Qualitative Analysis: Clinical Trials Packaging and Labelling Market, 2020-2030
3.1 Market Drivers
3.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
3.1.2 Technological Advancements
3.1.3 Regulatory Scenario
3.2 Market Restraints
3.2.1 Lack of Skilled Labor
3.3 Market Opportunities
3.3.1 Tamper Proof Packaging
3.3.2 Environmentally Safe Packaging
3.4 Market Challenges
3.4.1 Highly Competitive Scenario
3.4.2 Low Volume Requirements of Clinical Trials Packaging Material
3.5 SWOT Analysis
3.5.1 Strengths
3.5.2 Weaknesses
3.5.3 Opportunities
3.5.4 Threats
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Industry rivalry
3.7.4 Threat of substitutes
3.7.5 Entry barriers
4 Global Clinical Trials Packaging and Labelling Market by Type, 2020-2030
4.1 Introduction
4.1.1 Primary Packaging
4.1.2 Secondary Packaging
5 Global Clinical Trials Packaging and Labelling Market by End Users, 2020-2030
5.1 Introduction
5.1.1 Drug Manufacturing Companies
5.1.2 Research Labs
5.1.3 CRO’s
6 Global Clinical Trials Packaging and Labelling Market, 2020-2030
7 North America Clinical Trials Packaging and Labelling Market, 2020-2030
7.1 U.S. Clinical Trials Packaging and Labelling Market, 2020-2030
7.2 Canada Clinical Trials Packaging and Labelling Market, 2020-2030
8 Europe Clinical Trials Packaging and Labelling Market, 2020-2030
8.1 Germany Clinical Trials Packaging and Labelling Market, 2020-2030
8.2 France Clinical Trials Packaging and Labelling Market, 2020-2030
8.3 United Kingdom (UK) Clinical Trials Packaging and Labelling Market, 2020-2030
8.4 Italy Clinical Trials Packaging and Labelling Market, 2020-2030
8.5 Spain Clinical Trials Packaging and Labelling Market, 2020-2030
8.6 Rest of Europe Clinical Trials Packaging and Labelling Market, 2020-2030
9 Asia Pacific Clinical Trials Packaging and Labelling Market, 2020-2030
9.1 China Clinical Trials Packaging and Labelling Market, 2020-2030
9.2 Japan Clinical Trials Packaging and Labelling Market, 2020-2030
9.3 India Clinical Trials Packaging and Labelling Market, 2020-2030
9.4 Australia Clinical Trials Packaging and Labelling Market, 2020-2030
9.5 ASEAN Clinical Trials Packaging and Labelling Market, 2020-2030
9.6 Rest of Asia Pacific Clinical Trials Packaging and Labelling Market, 2020-2030
10 Latin America Clinical Trials Packaging and Labelling Market, 2020-2030
10.1 Brazil Clinical Trials Packaging and Labelling Market, 2020-2030
10.2 Mexico Clinical Trials Packaging and Labelling Market, 2020-2030
10.3 Rest of Latin America Clinical Trials Packaging and Labelling Market, 2020-2030
11 MEA Clinical Trials Packaging and Labelling Market, 2020-2030
11.1 GCC Clinical Trials Packaging and Labelling Market, 2020-2030
11.2 South Africa Clinical Trials Packaging and Labelling Market, 2020-2030
11.3 Rest of MEA Clinical Trials Packaging and Labelling Market, 2020-2030
12 Leading Companies in the Clinical Trials Packaging and Labelling Market, 2020-2030
12.1 Fisher Clinical Services, Inc.
12.1.1 Company Overview
12.1.2 Product Portfolio
12.1.3 Recent Initiatives
12.2 The Coghlan Group, Inc.
12.2.1 Company Overview
12.2.2 Product Portfolio
12.2.3 Recent Initiatives
12.3 Mawdsley-Brooks & Co. Ltd
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Product Portfolio
12.3.4 Recent Initiatives
12.4 Piramal Enterprises Ltd
12.4.1 Overview
12.4.2 Financial Overview
12.4.3 Product Portfolio
12.5 Sharp
12.5.1 Company Overview
12.5.2 Product Portfolio
12.5.3 Recent Initiatives
12.6 Corden Pharma GmbH
12.6.1 Company Overview
12.6.2 Product Portfolio
12.6.3 Recent Initiatives
12.7 Bilcare Limited
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Product Portfolio
12.7.4 Recent Initiatives
12.8 Westrock Company
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Product Portfolio
12.8.4 Recent Initiatives
12.9 Sentry Biopharma Services
12.9.1 Company Overview
12.9.2 Product Portfolio
12.10 Körber Medipak Systems AG
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Product Portfolio
12.10.4 Recent Initiatives
12.11 PCI Pharma Services
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Product Portfolio
12.11.4 Recent Initiatives
12.12 Nextpharma Technologies
12.12.1 Company Overview
12.12.2 Financial Overview
12.12.3 Product Portfolio
12.12.4 Recent Initiatives
12.13 CSM
12.13.1 Company Overview
12.13.2 Financial Overview
12.13.3 Product Portfolio
13 Conclusion of the Clinical Trials Packaging and Labelling Market, 2020-2030
14 Glossary
Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 4.1 Global Clinical Trials Packaging and Labelling Market Forecast by Type: Revenues (US$ million), AGR (%), 2019-2030
Table 4.2 Global Clinical Trials Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 4.3 Global Clinical Trials Packaging and Labelling Market Forecast for Primary Packaging: Revenue (US$ million), AGR (%), 2020-2030
Table 4.4 Global Clinical Trials Packaging and Labelling Market Forecast by for Primary Packaging: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 4.5 Global Clinical Trials Packaging and Labelling Market Forecast for Primary Packaging: Revenue (US$ million), AGR (%), 2019-2030
Table 4.6 Global Clinical Trials Packaging and Labelling Market Forecast by for Primary Packaging: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 5.1 Global Clinical Trials Packaging and Labelling Market Forecast by End Users: Revenue (US$ million), AGR (%), 2019-2030
Table 5.2 Global Clinical Trials Packaging and Labelling Market Forecast by End Users: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 6.1 Global Clinical Trials Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
Table 6.2 Global Clinical Trials Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 7.1 North America Clinical Trials Packaging and Labelling Market Forecast by Country: Revenue (US$ million), AGR (%), 2019-2030
Table 7.2 North America Clinical Trials Packaging and Labelling Market Forecast by Country: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 7.3 North America Clinical Trials Packaging and Labelling Market Forecast by Type: Revenue (US$ million), AGR (%), 2019-2030
Table 7.4 North America Clinical Trials Packaging and Labelling Market Forecast by Type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 7.5 North America Clinical Trials Packaging and Labelling Market Forecast by End User: Revenue (US$ million), AGR (%), 2019-2030
Table 7.6 North America Clinical Trials Packaging and Labelling Market Forecast by End User: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 7.6 U.S. Clinical Trials Packaging and Labelling Market Forecast: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
